TAF/FTC/DRV/c
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TAF/FTC/DRV/c, covering 2022-06-22 to 2022-06-22. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c) [Phase 4]